COM:SILENCE-THERAPEUTICS

Silence Therapeutics

Stock

Last Close

540.00

01/01 00:00

Volume Today

913.53K

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20
net income	-9.00M -	-11.09M 23.17%	-6.64M 40.07%	-8.44M 27.01%	-1.62M 80.83%	-18.41M 1,037.89%	-19.58M 6.36%	-32.55M 66.21%
depreciation and amortization	297K -	332K 11.78%	182K 45.18%	310K 70.33%	433K 39.68%	399K 7.85%	482K 20.80%	428K 11.20%
deferred income tax
stock based compensation	1.59M -	1.13M 28.94%	777K 31.06%	475K 38.87%	638K 34.32%	681K 6.74%	584K 14.24%	2.71M 363.36%
change in working capital	125K -	52K 58.40%	-1.12M 2,259.62%	-539K 52.00%	1.71M 417.44%	913K 46.64%	21.09M 2,209.42%	26.93M 27.70%
accounts receivables
inventory
accounts payables
other working capital
other non cash items	238K -	121K 49.16%	-1.45M 1,295.04%	-1.87M 29.46%	-10.76M 474.95%	-342K 96.82%	-842K 146.20%	4.16M 593.94%
net cash provided by operating activities	-6.76M -	-9.46M 39.96%	-8.26M 12.70%	-10.07M 21.94%	-9.60M 4.64%	-16.76M 74.60%	1.73M 110.30%	1.67M 3.18%
investments in property plant and equipment	-138K -	-338K 144.93%	-850K 151.48%	-537K 36.82%	-173K 67.78%	-188K 8.67%	-9K 95.21%	-794K 8,722.22%
acquisitions net
purchases of investments	-5M -			-4.30M -	-4.92M 14.47%	-5M 1.61%	-15M 200%	-40.04M 166.95%
sales maturities of investments			5M -		18.12M -	319K 98.24%
other investing activites	40K -	137K 242.50%	175K 27.74%	161K 8%	-15K 109.32%	39K 360%	-6K 115.38%	-418K 6,866.67%
net cash used for investing activites	-5.10M -	-201K 96.06%	4.33M 2,251.74%	-4.67M 208.09%	13.01M 378.37%	-4.83M 137.11%	-15.02M 210.87%	-41.25M 174.75%
debt repayment
common stock issued	18.78M -	10.84M 42.27%	39.15M 261.06%		48K -	341K 610.42%	5.27M 1,446.33%	31.61M 499.51%
common stock repurchased				-101K -
dividends paid
other financing activites
net cash used provided by financing activities	18.78M -	10.84M 42.27%	39.15M 261.06%	-101K 100.26%	48K 147.52%	341K 610.42%	5.27M 1,446.33%	31.61M 499.51%
effect of forex changes on cash	51K -	-220K 531.37%	-173K 21.36%	1.95M 1,225.43%	270K 86.13%	-2K 100.74%	36K 1,900%	-336K 1,033.33%
net change in cash	6.98M -	967K 86.15%	35.05M 3,524.61%	-12.89M 136.79%	3.73M 128.95%	-21.25M 669.27%	-7.98M 62.45%	-6.39M 19.96%
cash at beginning of period	8.91M -	15.89M 78.36%	16.86M 6.09%	51.91M 207.93%	39.01M 24.84%	42.74M 9.57%	21.49M 49.72%	27.03M 25.76%
cash at end of period	15.89M -	16.86M 6.09%	51.91M 207.93%	39.01M 24.84%	42.74M 9.57%	21.49M 49.72%	13.52M 37.12%	20.64M 52.75%
operating cash flow	-6.76M -	-9.46M 39.96%	-8.26M 12.70%	-10.07M 21.94%	-9.60M 4.64%	-16.76M 74.60%	1.73M 110.30%	1.67M 3.18%
capital expenditure	-138K -	-338K 144.93%	-850K 151.48%	-537K 36.82%	-173K 67.78%	-188K 8.67%	-9K 95.21%	-794K 8,722.22%
free cash flow	-6.89M -	-9.79M 42.07%	-9.11M 7.03%	-10.60M 16.45%	-9.77M 7.84%	-16.95M 73.43%	1.72M 110.14%	878K 48.89%

All numbers in (except ratios and percentages)